Updated July 2026 · 7 min read

Isoproterenol (Isuprel): The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Isoproterenol is the pure beta-agonist you hang when the heart is too slow and nothing else is working — a chemical pacemaker that speeds conduction and the rate. It is used in narrow, specific situations, and because it drives up myocardial oxygen demand, it demands a clear reason. Here is where it fits.

How isoproterenol works

Isoproterenol stimulates beta-1 receptors in the heart — raising rate (chronotropy), contractility (inotropy), and AV conduction (dromotropy) — and beta-2 receptors in vessels and bronchi, causing vasodilation and bronchodilation. It has no alpha effect at all, so unlike epinephrine it does not vasoconstrict; the beta-2 vasodilation can actually drop diastolic pressure. The net picture is a faster, harder-pumping heart with dilated vessels — useful when the problem is an unacceptably slow rate, risky when the heart can't afford the extra oxygen cost.

Dosing and titration

Isoproterenol is titrated to a heart-rate or symptom endpoint with continuous ECG and blood-pressure monitoring. It is generally a bridge, not a destination — a way to hold the rate up while a transvenous or permanent pacemaker is arranged, or while a reversible cause (drug toxicity, ischemia) is treated. Because it raises rate and contractility together, it substantially increases myocardial oxygen consumption.

Where it fits

Refractory bradycardia and heart block. When atropine and, in many protocols, dopamine or epinephrine haven't restored an adequate rate, isoproterenol can drive it up as a bridge to pacing.

Bradycardia-dependent torsades. By increasing the rate, it shortens the QT and suppresses the pauses that trigger polymorphic VT — often alongside magnesium and overdrive pacing.

Specialized settings. It is used in electrophysiology studies to provoke arrhythmias, in Brugada and certain electrical-storm scenarios, and after heart transplantation (the denervated heart relies on circulating catecholamines for rate).

Risks to monitor

Tachyarrhythmias. Beta stimulation can provoke atrial and ventricular arrhythmias — the very problem you may be trying to avoid.

Hypotension. Beta-2 vasodilation lowers diastolic pressure; in a volume-depleted patient the mean pressure can fall despite the faster rate.

Why CRNA students should know it

On the CRNA path, isoproterenol illustrates pure beta pharmacology cleanly — no alpha to muddy the picture — which makes it a teaching favorite for receptor physiology. It appears in transplant anesthesia and in managing perioperative bradyarrhythmias, and understanding how it trades rate for oxygen demand is exactly the hemodynamic judgment anesthesia requires.

Bottom line

Isoproterenol is the pure beta-agonist chemical pacemaker: it speeds the slow heart and shortens the QT in bradycardia-dependent torsades, usually as a bridge to pacing. Respect the oxygen-demand cost, the arrhythmia potential, and the diastolic-pressure drop, and reserve it for the specific situations where a faster rate is genuinely the goal. Learn the receptor logic now.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.